title: [Corpus cavernosum injection treatment of erectile impotence].
abstract: Through the use of vasoactive substances an improvement of diagnosis and treatment of men suffering from erectile dysfunction was obtained. From June 1988 to December 1989 in 108 patients an intracavernous injection therapy trial was performed. The response rate 85% and in 69% of the patients an organic disorders was found. Five percent of the patients have had a prolonged erection after intracavernous papaverine phentolamine injection. All cases have been treated successfully by local use of the sympaticomimetics Noradrenaline. The use of vasoactive substances is the method of choice in diagnosis and treatment of erectile dysfunction.
authors.affiliation: Klinik und Poliklinik für Urologie Humboldt-Universität zu Berlin.
authors.forename: S
authors.initials: S
authors.lastname: Lenk
authors.forename: G
authors.initials: G
authors.lastname: Schönherr
authors.forename: I
authors.initials: I
authors.lastname: Korner
mesh_terms: D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage*; D010410:Penile Erection / Q000187:drug effects; D010413:Penis / Q000098:blood supply*; D010646:Phentolamine / Q000008:administration & dosage*
chemical_list: D010208:Papaverine; D010646:Phentolamine
vernacular_title: Schwellkörperinjektionsbehandlung bei erektiler Impotenz.